bipolar disorder: A disorder of the brain that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks. Often these moods range and shift from periods of elation and energized behavior to those of hopelessness and depression.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1218 |
4. Check minimum number of eventsNone |
1218 |
5. Include endpointsNone |
1218 |
6. Filter based on genotype QC (FinnGen only) |
1218 |
Control definitions (FinnGen only)
- Control exclude
- F5_MOOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F30-F39
- Name in latin
- Mania
Similar endpoints
↥List of similar endpoints to
Manic episode
based on the number of shared cases.
Similar with more cases:
- Mood [affective] disorders
- Mood disorders
- Mood disorders, excluding more controls
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8563 | 4317 | 4191 |
| Only index persons | 7736 | 3974 | 3762 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.12 | 0.12 |
| Only index persons | 0.14 | 0.15 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 47.10 | 47.61 | 46.64 |
| Only index persons | 45.55 | 45.98 | 45.08 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1218 | 676 | 542 |
| Unadjusted period prevalence (%) | 0.23 | 0.23 | 0.24 |
| Median age at first event (years) | 43.84 | 41.85 | 46.32 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1122
- Matched controls
- 11220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
1553.9
323.0
512
6
N05AX12
ATC
aripiprazole; systemic
95.5
323.0
428
72
F30.0
ICD-10 Finland
Hypomania
+∞
323.0
307
*
N05AH03
ATC
olanzapine; systemic
138.7
323.0
676
121
N05AH04
ATC
quetiapine; oral
51.8
323.0
819
557
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
+∞
323.0
353
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4227.0
323.0
452
*
N05AN01
ATC
lithium; oral
319.0
323.0
456
24
N03AG01
ATC
valproic acid; systemic, rectal
77.9
323.0
623
177
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4394.9
323.0
330
*
F30.9
ICD-10 Finland
Manic episode, unspecified
+∞
323.0
399
*
N05AX08
ATC
risperidone; systemic
35.0
323.0
440
203
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
+∞
323.0
365
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
167.3
323.0
814
174
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
+∞
319.5
291
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
56.7
317.0
374
98
F30.20
ICD-10 Finland
Mania with mood-congruent psychotic symptoms
+∞
303.3
277
*
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
+∞
290.6
266
*
N03AX09
ATC
lamotrigine; oral
53.0
286.0
342
92
N05AA02
ATC
levomepromazine; systemic
48.0
246.7
301
85
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2581.6
238.2
222
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
1371.9
235.0
221
*
F30.1
ICD-10 Finland
Mania without psychotic symptoms
+∞
229.2
212
*
F31
ICD-10 Finland
Bipolar affective disorder
2449.1
228.1
213
*
N05BA04
ATC
oxazepam; oral
8.1
191.9
535
1138
P99
ICPC
Psychological disorders other
48.7
191.7
233
60
F32.9
ICD-10 Finland
Depressive episode, unspecified
20.3
188.4
294
193
N05AF03
ATC
chlorprothixene; systemic
49.2
161.6
196
48
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
11.7
153.3
307
350
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
62.6
150.7
175
33
N06AB04
ATC
citalopram; systemic
6.9
144.9
430
924
N05BA06
ATC
lorazepam; systemic, sublingual
24.4
144.8
210
105
N05AB03
ATC
perphenazine; systemic, rectal
30.5
142.3
193
76
T36
ICD-10 Finland
Poisoning by systemic antibiotics
26.7
139.3
196
88
N05CD07
ATC
temazepam; oral
10.1
135.1
293
380
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
73.6
135.0
153
24
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
+∞
133.0
125
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
87.9
132.1
146
19
P29
ICPC
Psychological sympt/compl other
12.6
130.0
247
246
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
70.8
129.9
148
24
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
52.3
125.1
150
33
N04AA02
ATC
biperiden; systemic
36.6
122.3
158
50
N05AD01
ATC
haloperidol; systemic
26.7
120.3
169
74
N05CF01
ATC
zopiclone; oral
4.9
119.5
515
1652
N06AB06
ATC
sertraline; oral
9.2
114.3
259
354
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
93.7
113.8
125
15
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
106.1
113.6
123
13
F39
ICD-10 Finland
Unspecified mood [affective] disorder
164.6
113.6
118
8
N05BA01
ATC
diazepam; systemic, rectal
7.3
111.7
302
542
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
30.2
110.7
150
57
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
110.8
110.4
119
12
N06AX11
ATC
mirtazapine; oral
4.6
108.7
493
1627
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
20.1
106.0
163
94
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
10.9
104.9
213
236
F31.2
ICD-10 Finland
Bipolar affective disorder, current episode manic with psychotic symptoms
+∞
102.7
97
*
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
+∞
102.7
97
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
110.7
102.0
110
11
IGY02
NOMESCO Finland
Psychiatric monitoring contact
49.2
101.5
123
28
N06AX16
ATC
venlafaxine; oral
7.0
96.0
262
467
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
67.6
95.8
110
18
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
49.2
94.9
115
26
N05AA01
ATC
chlorpromazine; systemic, rectal
35.3
94.6
123
39
IGY99
NOMESCO Finland
Other psychiatric treatment contact
60.2
93.2
109
20
N07BB01
ATC
disulfiram; oral
13.5
92.0
166
142
N06AB03
ATC
fluoxetine; oral
7.1
91.7
247
430
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
+∞
86.6
82
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
193.1
86.5
89
5
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
+∞
85.5
81
*
SPAT1240
SPAT
Therapeutic discussion
5.7
82.3
266
580
N05AH02
ATC
clozapine; systemic
21.4
82.2
123
64
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
7.2
82.2
217
363
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
75.0
79.6
90
13
N05AC02
ATC
thioridazine; oral
22.5
78.9
116
57
P73
ICPC
Affective psychosis
415.5
78.9
78
*
N06AX12
ATC
bupropion; oral
12.6
78.5
146
132
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
789.6
76.2
74
*
N05AF05
ATC
zuclopenthixol; systemic
34.5
72.8
95
30
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
104.7
71.9
78
8
N06AB10
ATC
escitalopram; oral
4.2
70.6
322
990
F30.2
ICD-10 Finland
Mania with psychotic symptoms
+∞
70.6
67
*
C07AA05
ATC
propranolol; systemic
4.0
70.2
339
1097
F61.0
ICD-10 Finland
Mixed personality disorders
75.9
69.2
78
11
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
38.7
67.8
86
24
F30.21
ICD-10 Finland
Mania with mood-incongruent psychotic symptoms
+∞
67.4
64
*
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
80.4
67.0
75
10
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
88.0
66.9
74
9
P72
ICPC
Schizophrenia
19.4
65.5
101
57
F99
ICD-10 Finland
Mental disorder, not otherwise specified
20.1
64.4
98
53
N06AX03
ATC
mianserin; oral
12.8
62.9
115
99
N05BE01
ATC
buspirone; oral
19.3
62.3
96
54
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
169.5
61.6
64
*
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
59.0
61.5
72
13
F10.20
ICD-10 Finland
Alcohol dependence currently independent
20.7
59.8
90
47
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
60.2
58.3
68
12
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
17.4
58.1
93
58
N03AE01
ATC
clonazepam; systemic
8.9
57.9
129
162
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
109.3
57.4
62
6
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.7
55.7
173
348
SPAT1234
SPAT
Support of social functional capacity
9.6
54.0
114
130
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
79.3
53.6
60
8
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.1
53.5
236
684
P76
ICPC
Depressive disorder
8.0
53.2
126
174
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
188.9
52.4
54
*
N05AE04
ATC
ziprasidone; systemic
100.0
52.3
57
6
P01
ICPC
Feeling anxious/nervous/tense
4.3
51.2
213
583
N03AF01
ATC
carbamazepine; oral, rectal
7.6
50.6
124
180
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.4
50.1
163
344
F60.9
ICD-10 Finland
Personality disorder, unspecified
45.9
50.0
61
14
P98
ICPC
Psychosis NOS/other
47.8
48.7
59
13
AA400
NOMESCO Finland
Electroconvulsive therapy
133.4
48.2
51
*
AA1AD
NOMESCO Finland
CT of head and brain
3.2
48.2
299
1132
N06AB05
ATC
paroxetine; oral
7.3
47.4
119
179
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
90.8
47.2
52
6
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
8.7
47.1
105
131
SPAT1254
SPAT
Administration of medicine
3.7
46.8
230
726
188
Kela drug reimbursment
Psychosis requiring demanding treatment
23.3
45.8
66
30
F51.0
ICD-10 Finland
Nonorganic insomnia
3.8
45.7
220
681
P03
ICPC
Feeling depressed
4.8
45.4
165
392
P27
ICPC
Fear of mental disorder
35.2
44.2
57
17
F20.9
ICD-10 Finland
Schizophrenia, unspecified
13.4
44.1
78
62
F10.25
ICD-10 Finland
Alcohol dependence continuous use
19.7
44.1
67
36
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
14.0
43.2
75
57
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
53.3
43.0
51
10
SPAT1243
SPAT
Psychiatric/psychological examination
10.1
42.3
86
91
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
30.9
42.1
56
19
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
11.7
41.9
79
72
N05BA12
ATC
alprazolam; oral
4.6
41.4
155
378
IGV01
NOMESCO Finland
Psychiatric network contact
69.9
41.4
47
7
F41.1
ICD-10 Finland
Generalized anxiety disorder
7.7
40.9
98
137
N05AH05
ATC
asenapine; oral
411.7
40.4
40
*
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
68.4
40.4
46
7
2962C
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]
+∞
39.8
38
*
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
207.1
39.1
40
*
2962E
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]
+∞
38.8
37
*
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
58.5
38.6
45
8
SPAT1307
SPAT
Psychosocial counselling and guidance
4.8
37.3
133
307
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
17.2
37.1
59
36
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
33.4
36.9
48
15
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
+∞
36.7
35
*
F30.8
ICD-10 Finland
Other manic episodes
+∞
36.7
35
*
IEY01
NOMESCO Finland
Psychoeducation, individual
83.0
36.0
40
5
A06AD11
ATC
lactulose; oral
3.6
35.5
179
567
R41.0
ICD-10 Finland
Disorientation, unspecified
10.4
35.2
70
71
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
69.0
35.2
40
6
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
16.3
34.6
56
36
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
+∞
34.6
33
*
N05AX13
ATC
paliperidone; systemic
37.2
33.9
43
12
N06AX26
ATC
vortioxetine; oral
6.7
33.9
89
142
P15
ICPC
Chronic alcohol abuse
8.9
33.6
73
87
N05CF02
ATC
zolpidem; oral
2.9
33.2
226
886
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
33.0
174
569
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
76.6
33.0
37
5
F10.24
ICD-10 Finland
Alcohol depence active use
18.4
33.0
51
29
N05AL01
ATC
sulpiride; systemic
20.4
32.9
49
25
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
120.3
32.8
35
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
32.7
261
1129
F34.1
ICD-10 Finland
Dysthymia
17.7
32.6
51
30
EBA00
NOMESCO Finland
Extraction of tooth
2.2
32.0
429
2428
F22.0
ICD-10 Finland
Delusional disorder
21.3
32.0
47
23
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.0
31.6
135
370
N06AA12
ATC
doxepin; systemic
7.1
31.3
79
119
IGY02
SPAT
NA
43.6
31.0
38
9
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
72.0
31.0
35
5
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
321.4
31.0
31
*
N06AX05
ATC
trazodone; oral
16.3
31.0
50
32
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
30.3
30.9
41
14
N06AG02
ATC
moclobemide; oral
7.3
30.5
75
109
P28
ICPC
Limited function/disability (P)
33.6
30.1
39
12
N05AE05
ATC
lurasidone; oral
310.4
29.9
30
*
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
14.9
29.9
50
35
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
109.7
29.8
32
*
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
46.4
29.8
36
8
F21
ICD-10 Finland
Schizotypal disorder
46.4
29.8
36
8
F05.9
ICD-10 Finland
Delirium, unspecified
14.6
29.1
49
35
IGP01
NOMESCO Finland
Psychiatric family contact
67.8
29.0
33
5
P74
ICPC
Anxiety disorder/anxiety state
6.3
28.6
78
131
R53
ICD-10 Finland
Malaise and fatigue
2.6
28.4
247
1113
P80
ICPC
Personality disorder
56.6
28.3
33
6
P06
ICPC
Sleep disturbance
3.4
28.3
150
491
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
11.1
28.2
54
51
29610
ICD-8 Finland
Affective psychoses, Manic-depression psychosis, manic type
+∞
28.2
27
*
H03AA01
ATC
levothyroxine sodium; systemic
2.5
28.2
267
1258
K02.1
ICD-10 Finland
Caries of dentine
2.0
27.9
693
4983
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
102.7
27.8
30
*
N05AD03
ATC
melperone; systemic
18.9
27.6
42
23
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.2
27.5
88
180
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
12.1
27.4
50
43
A04
ICPC
Weakness/tiredness general
3.0
27.3
169
617
A28
ICPC
Limited function/disability NOS
3.3
27.2
150
504
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.4
27.1
104
257
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
63.7
27.1
31
5
L17
ICPC
Foot/toe symptom/complaint
2.3
26.8
289
1453
N06AX21
ATC
duloxetine; oral
3.6
26.7
127
381
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
23.9
26.2
37
16
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
26.2
262
1265
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
16.1
26.0
42
27
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
7.0
26.0
65
97
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
138.2
25.7
27
*
SPAT1301
SPAT
No procedures
2.1
25.7
359
2023
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
45.4
25.6
31
7
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
9.5
25.2
52
57
F10.09
ICD-10 Finland
Alcohol intoxication UNS
9.1
25.0
53
61
N05AB01
ATC
dixyrazine; systemic
24.0
24.9
35
15
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
24.8
820
6433
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
255.5
24.8
25
*
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
92.2
24.7
27
*
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
35.4
24.4
31
9
R60.0
ICD-10 Finland
Localized oedema
3.3
24.2
131
434
2962D
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,VAIKEA-ASTEINEN]
+∞
24.0
23
*
IER01
NOMESCO Finland
Psychoeducation, group
38.5
24.0
30
8
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.8
23.9
172
689
F32.1
ICD-10 Finland
Moderate depressive episode
5.5
23.8
72
138
F25
ICD-10 Finland
Schizoaffective disorders
127.7
23.7
25
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
6.0
23.4
66
116
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.4
23.4
118
370
Z71.8
ICD-10 Finland
Other specified counselling
2.2
23.3
297
1596
K59.09
ICD-10 Finland
Constipation, unspecified
4.5
23.3
85
200
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
23.2
363
2129
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
55.2
23.1
27
5
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
66.4
22.9
26
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
16.9
22.8
36
22
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
85.2
22.7
25
*
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
234.6
22.7
23
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
28.0
22.3
30
11
N06AB08
ATC
fluvoxamine; oral
8.1
22.2
50
64
RS220
NOMESCO Finland
NA
11.5
22.0
41
37
2962A
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA NUD]
+∞
21.9
21
*
P19
ICPC
Drug abuse
14.1
21.9
37
27
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
44.3
21.5
26
6
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
17.9
21.4
33
19
SPAT1216
SPAT
Assessment of functional ability
2.7
21.3
154
617
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
21.2
88
234
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
34.5
21.2
27
8
WX110
NOMESCO Finland
Local anesthesy
1.9
21.1
778
6125
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.4
21.1
108
342
D12
ICPC
Constipation
6.9
21.1
53
80
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.8
21.0
621
4532
X78
ICD-10 Finland
Intentional self-harm by sharp object
28.7
21.0
28
10
F50.9
ICD-10 Finland
Eating disorder, unspecified
22.0
20.9
30
14
F06.30
ICD-10 Finland
Organic manic syndrome
213.8
20.6
21
*
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
213.8
20.6
21
*
F40.1
ICD-10 Finland
Social phobias
8.9
20.2
43
50
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
20.2
555
3931
T90
ICPC
Diabetes non-insulin dependent
2.2
20.1
222
1111
N05BA02
ATC
chlordiazepoxide; systemic
7.2
20.1
49
71
N06AA09
ATC
amitriptyline; systemic
3.2
20.0
109
362
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
19.9
309
1784
2967A
ICD-9 Finland
Affective psychoses, Bipolar affective disorder, unspecified
+∞
19.8
19
*
R25.1
ICD-10 Finland
Tremor, unspecified
6.8
19.8
50
76
N05AF01
ATC
flupentixol; systemic
11.2
19.8
37
34
S06.0
ICD-10 Finland
Concussion
2.8
19.8
137
532
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
106.9
19.6
21
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
56.0
19.0
22
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
18.8
18
*
29630
ICD-8 Finland
Affective psychoses, Manic-depressive psychosis, circular type
+∞
18.8
18
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.4
18.7
93
288
L28
ICPC
Limited function/disability (L)
2.6
18.7
144
594
SPAT1310
SPAT
Counselling related to known health issue
1.9
18.6
351
2174
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
101.8
18.6
20
*
IAB11
NOMESCO Finland
Psychiatric mood consultation
193.1
18.6
19
*
F32.8
ICD-10 Finland
Other depressive episodes
30.6
18.4
24
8
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.5
18.3
43
59
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
18.3
616
4599
N05CD02
ATC
nitrazepam; oral
11.3
18.3
34
31
-1
NOMESCO Finland
NA
1.8
18.3
413
2718
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.8
18.2
80
224
B18.2
ICD-10 Finland
Chronic viral hepatitis C
10.0
18.2
36
37
T74.1
ICD-10 Finland
Physical abuse
6.4
18.2
48
78
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
18.1
409
2689
SAA02
NOMESCO Finland
Basic examination of mouth
1.8
18.1
739
5846
29999
ICD-8 Finland
Unspecified psychosis
20.4
17.8
26
13
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
67.7
17.8
20
*
N06BA04
ATC
methylphenidate; oral
6.5
17.8
46
73
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
+∞
17.8
17
*
F60.8
ICD-10 Finland
Other specific personality disorders
96.6
17.6
19
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.1
17.6
228
1217
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
15.9
17.5
28
18
WX290
NOMESCO Finland
Other blockade of nerve
1.7
17.3
537
3886
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
42.7
17.3
21
5
N06AX22
ATC
agomelatine; oral
9.5
17.2
35
38
N06AA06
ATC
trimipramine; systemic
7.5
17.1
40
55
F60.0
ICD-10 Finland
Paranoid personality disorder
50.8
17.0
20
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
50.8
17.0
20
*
P16
ICPC
Acute alcohol abuse
7.7
17.0
39
52
F60.5
ICD-10 Finland
Anankastic personality disorder
22.3
16.9
24
11
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
22.3
16.9
24
11
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
7.6
16.8
39
53
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
64.3
16.8
19
*
SPAT1241
SPAT
Extensive assessment of psychosocial situation
9.0
16.7
35
40
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
+∞
16.7
16
*
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
+∞
16.7
16
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
16.7
453
3133
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
91.4
16.6
18
*
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
28.0
16.5
22
8
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.5
16.5
49
93
SPAT1227
SPAT
Substance abuse rehabilitation
20.4
16.5
24
12
A46
ICD-10 Finland
Erysipelas
2.5
16.4
142
626
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
40.7
16.4
20
5
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
16.3
425
2899
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
30.5
16.1
21
7
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
48.2
16.1
19
*
N06AX18
ATC
reboxetine; oral
13.8
16.0
27
20
P50
ICPC
Psychological, Medication/prescr/renewal
21.3
16.0
23
11
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
16.0
134
579
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
60.9
15.8
18
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
15.8
200
1052
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
15.8
267
1575
V03AA01
ATC
NA
8.9
15.8
33
38
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.6
15.7
124
520
XA800
NOMESCO Finland
Neuropsychological investigation
3.9
15.7
65
174
F34.0
ICD-10 Finland
Cyclothymia
162.1
15.5
16
*
KMAK
NOMESCO Finland
NA
1.7
15.5
599
4560
IEV99
NOMESCO Finland
Other psychiatric network intervention
38.6
15.4
19
5
K08.3
ICD-10 Finland
Retained dental root
3.1
15.4
88
302
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
7.4
15.3
36
50
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
15.3
210
1140
Z72.2
ICD-10 Finland
Drug use
23.7
15.1
21
9
F61
ICD-10 Finland
Mixed and other personality disorders
45.6
15.1
18
*
SPAT1252
SPAT
Overall medication plan or its review
3.3
15.1
78
250
N03AX11
ATC
topiramate; oral
5.6
14.9
43
79
P18
ICPC
Medication abuse
25.4
14.7
20
8
F50.1
ICD-10 Finland
Atypical anorexia nervosa
25.4
14.7
20
8
SPAT1263
SPAT
Sampling
1.7
14.7
448
3175
A10BA02
ATC
metformin; oral
1.9
14.7
242
1408
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
14.6
143
667
SPAT1260
SPAT
Consultation of another employee
2.1
14.6
190
1009
F12.5
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, psychotic disorder
+∞
14.6
14
*
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
81.2
14.6
16
*
F60.7
ICD-10 Finland
Dependent personality disorder
81.2
14.6
16
*
F41.09
ICD-10 Finland
UNS Panic Syndrome
5.2
14.5
45
90
RF220
NOMESCO Finland
NA
9.0
14.5
30
34
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
10.2
14.5
28
28
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
151.9
14.5
15
*
L03
ICPC
Low back symptom/complaint
1.9
14.4
243
1426
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.4
14.3
51
119
C07AB07
ATC
bisoprolol; oral
1.7
14.2
388
2655
Z03
ICPC
Housing/neighbourhood problem
22.6
14.2
20
9
Z08
ICPC
Social welfare problem
13.6
14.2
24
18
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
14.1
420
2945
SPAT1235
SPAT
Mental health, emotional support
16.0
14.0
22
14
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
13.9
157
785
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
13.7
73
239
OAB43
SPAT
NA
0.4
13.7
61
1413
K59.0
ICD-10 Finland
Constipation
3.5
13.6
65
196
R06.0
ICD-10 Finland
Dyspnoea
1.9
13.6
227
1327
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
34.5
13.5
17
5
N06AA22
ATC
NA
34.5
13.5
17
5
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
34.5
13.5
17
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
13.5
107
447
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
10.2
13.5
26
26
F25.81
ICD-10 Finland
Other specified schizoaffective disorder with prolonged schizophrenic than bipolar symptoms
141.6
13.5
14
*
IEP99
NOMESCO Finland
Other psychiatric family intervention
141.6
13.5
14
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.4
367
2504
A29
ICPC
General symptom/complaint other
2.4
13.3
118
526
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
6.5
13.3
34
54
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
13.1
99
404
A27
ICPC
Fear of other disease NOS
3.7
13.1
57
160
Z72.0
ICD-10 Finland
Tobacco use
4.9
13.1
42
88
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
13.0
95
380
F05.8
ICD-10 Finland
Other delirium
13.2
12.9
22
17
C03CA01
ATC
furosemide; systemic
1.9
12.9
210
1211
E86
ICD-10 Finland
Volume depletion
7.1
12.9
31
45
S01.0
ICD-10 Finland
Open wound of scalp
2.8
12.8
83
310
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
12.7
140
693
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.9
12.6
28
36
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.2
12.6
47
115
EBA30
NOMESCO Finland
Excision of root of tooth
3.2
12.6
67
220
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
32.4
12.6
16
5
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
12.5
317
2109
N05AC01
ATC
periciazine; systemic
24.6
12.5
17
7
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
20.3
12.5
18
9
S10
ICPC
Boil/carbuncle
3.2
12.4
65
211
A01
ICPC
Pain general/multiple sites
2.7
12.3
84
323
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
10.6
12.3
23
22
RT250
NOMESCO Finland
NA
38.0
12.2
15
*
G25.1
ICD-10 Finland
Drug-induced tremor
38.0
12.2
15
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
38.0
12.2
15
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
12.2
216
1283
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
5.7
12.1
34
61
N03AX16
ATC
pregabalin; oral
1.9
12.1
209
1230
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.4
12.0
72
1496
S22
ICPC
Nail symptom/complaint
3.0
12.0
69
238
R4140
NOMESCO Finland
Psychotherapy
21.5
12.0
17
8
RS221
NOMESCO Finland
NA
6.5
11.9
30
47
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
47.2
11.9
14
*
N05AX15
ATC
cariprazine; oral
47.2
11.9
14
*
F60.1
ICD-10 Finland
Schizoid personality disorder
47.2
11.9
14
*
S21
ICPC
Skin texture symptom/complaint
2.2
11.9
125
602
Z02.7
ICD-10 Finland
Issue of medical certificate
3.0
11.7
68
237
R51.80
ICD-10 Finland
Headache
2.0
11.7
161
869
M79.6
ICD-10 Finland
Pain in limb
1.6
11.7
338
2325
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
11.7
84
334
29580
ICD-8 Finland
Schizophrenia, Other
16.6
11.7
18
11
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
65.6
11.6
13
*
SPAT1229
SPAT
Assessment of need for aid
2.9
11.6
72
262
N03AX12
ATC
gabapentin; oral
2.1
11.6
141
726
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.2
11.6
128
632
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
11.6
621
4977
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
11.6
227
1392
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
23.2
11.6
16
7
N06AX17
ATC
milnacipran; oral
10.2
11.5
22
22
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
+∞
11.5
11
*
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
+∞
11.5
11
*
IBC98
NOMESCO Finland
Other child protection assessment
121.2
11.4
12
*
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
121.2
11.4
12
*
SPAT1265
SPAT
Breathalyser
8.4
11.3
24
29
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
9.0
11.3
23
26
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
35.4
11.3
14
*
Z00.8
ICD-10 Finland
Other general examinations
2.6
11.3
85
348
L15
ICPC
Knee symptom/complaint
1.8
11.2
200
1188
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
25.3
11.2
15
6
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
25.3
11.2
15
6
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
20.3
11.1
16
8
S29
ICPC
Skin symptom/complaint other
1.9
11.1
162
895
F20
ICD-10 Finland
Schizophrenia
11.3
11.1
20
18
S18
ICPC
Laceration/cut
1.6
11.1
378
2707
A99
ICPC
Disease/condition unspecnature/site
2.5
11.0
84
346
U02
ICPC
Urinary frequency/urgency
2.1
11.0
130
660
N17
ICPC
Vertigo/dizziness
2.3
11.0
103
473
SPAT1276
SPAT
Outlining of treatment with patient or their family members
5.4
10.9
32
61
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
43.8
10.9
13
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.2
10.9
40
97
SPAT1251
SPAT
Organisation of medication
3.6
10.8
47
133
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
10.7
10.8
20
19
F41.00
ICD-10 Finland
Moderate panic disorder
7.3
10.8
25
35
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.5
10.8
31
58
F60.2
ICD-10 Finland
Dissocial personality disorder
28.3
10.7
14
5
RT150
NOMESCO Finland
NA
28.3
10.7
14
5
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
28.3
10.7
14
5
R96
ICPC
Asthma
2.5
10.7
87
369
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
10.7
126
639
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
21.7
10.7
15
7
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
10.7
96
432
SPAT1237
SPAT
Psychotherapy
13.0
10.7
18
14
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
13.0
10.7
18
14
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
60.6
10.6
12
*
ICB03
SPAT
NA
60.6
10.6
12
*
N06AA04
ATC
clomipramine; systemic
6.1
10.6
28
47
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
10.6
212
1302
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
8.1
10.6
23
29
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
10.6
108
515
F50.0
ICD-10 Finland
Anorexia nervosa
11.3
10.6
19
17
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
+∞
10.4
10
*
F30
ICD-10 Finland
Manic episode
+∞
10.4
10
*
P20
ICPC
Memory disturbance
2.6
10.4
79
323
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
32.8
10.3
13
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
32.8
10.3
13
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
32.8
10.3
13
*
RS210
NOMESCO Finland
NA
32.8
10.3
13
*
RS140
NOMESCO Finland
NA
32.8
10.3
13
*
29899
ICD-8 Finland
Other psychoses, Reactive psychosis, unspecified
32.8
10.3
13
*
M54.5
ICD-10 Finland
Low back pain
1.6
10.3
315
2184
SPAT1053
SPAT
Memory test
2.3
10.3
98
453
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
10.3
91
407
F93.89
ICD-10 Finland
Other childhood emotional disorders
23.6
10.3
14
6
R05
ICPC
Cough
1.7
10.2
224
1416
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.8
10.2
199
1214
G72.8
ICD-10 Finland
Other specified myopathies
8.0
10.1
22
28
D01
ICPC
Abdominal pain/cramps general
2.1
10.1
118
598
A10BH01
ATC
sitagliptin; oral
2.5
10.1
80
335
R03BB04
ATC
tiotropium bromide; inhalant
2.5
10.1
78
325
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
14.7
10.0
16
11
U04
ICPC
Incontinence urine
3.7
10.0
43
121
R2
NOMESCO Finland
Guidance supporting rehabilitation
40.4
10.0
12
*
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
40.4
10.0
12
*
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
16.9
9.9
15
9
F03
ICD-10 Finland
Unspecified dementia
4.5
9.9
34
78
L29
ICPC
Musculoskeletal sympt/complt other
2.6
9.9
73
296
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
12.3
9.9
17
14
RS230
NOMESCO Finland
NA
12.3
9.9
17
14
IBA03
NOMESCO Finland
Psychotherapy evaluation
26.3
9.8
13
5
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
9.8
268
1800
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
9.8
191
1164
Z00.0
ICD-10 Finland
General medical examination
1.8
9.8
189
1150
P17
ICPC
Tobacco abuse
6.2
9.7
25
41
29599
ICD-8 Finland
Schizophrenia, Unspecified type
13.5
9.7
16
12
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
13.5
9.7
16
12
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
13.5
9.7
16
12
N02BE01
ATC
paracetamol; systemic, rectal
1.6
9.6
873
7733
IHZ04
SPAT
NA
11.5
9.6
17
15
SPAT1262
SPAT
Handing over of treatment supplies
1.8
9.5
159
921
Z29
ICPC
Social problem NOS
5.5
9.5
27
50
F20.8
ICD-10 Finland
Other schizophrenia
15.2
9.5
15
10
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
9.5
248
1646
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
9.5
312
2199
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.8
9.5
39
106
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
9.4
142
794
F84.5
ICD-10 Finland
Asperger syndrome
17.7
9.4
14
8
W0A10
NOMESCO Finland
Mapping of psychosocial situation
30.3
9.4
12
*
F23.01
ICD-10 Finland
Acute polymorphic psychosis without an actual schizophrenic disease picture with an acute stress factor
+∞
9.4
9
*
F53.1
ICD-10 Finland
Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
9.4
9
*
F06.31
ICD-10 Finland
Organic bipolar syndrome
+∞
9.4
9
*
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
21.9
9.4
13
6
I95.9
ICD-10 Finland
Hypotension, unspecified
7.0
9.3
22
32
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.9
9.3
29
60
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.2
9.3
48
156
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
9.3
67
269
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
9.2
69
281
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
9.2
98
477
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
13.8
9.2
15
11
SPAT1101
SPAT
Orthostatic test
3.7
9.2
39
109
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
9.1
46
147
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.1
325
2333
WZA90
NOMESCO Finland
Other doctors statement
1.6
9.1
240
1594
F41.01
ICD-10 Finland
Severe panic disorder
11.6
9.1
16
14
Z72.1
ICD-10 Finland
Alcohol use
7.1
9.0
21
30
N06BA09
ATC
atomoxetine; oral
37.0
9.0
11
*
F23.20
ICD-10 Finland
Acute schizophrenia-like psychosis without acute stress factor
37.0
9.0
11
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.7
9.0
38
106
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
9.0
74
319
K04.0
ICD-10 Finland
Pulpitis
2.0
9.0
115
603
SGC10
NOMESCO Finland
Covering pulpa of tooth
2.0
8.9
113
589
R95
ICPC
Chron obstructive pulmonary disease
4.7
8.9
29
63
T86
ICPC
Hypothyroidism/myxoedema
3.3
8.9
43
133
R44.3
ICD-10 Finland
Hallucinations, unspecified
24.2
8.9
12
5
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
24.2
8.9
12
5
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
12.6
8.9
15
12
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
8.9
68
283
F20.0
ICD-10 Finland
Paranoid schizophrenia
8.0
8.9
19
24
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.2
8.7
44
141
T82
ICPC
Obesity
3.0
8.7
48
164
R1250
NOMESCO Finland
Evaluation of functional capability
4.9
8.7
27
56
A02BC01
ATC
omeprazole; systemic
1.6
8.7
236
1576
K59.1
ICD-10 Finland
Functional diarrhoea
2.9
8.7
51
181
F23.10
ICD-10 Finland
Acute polymorphic psychosis with schizophrenic disease picture without acute stress factor
50.4
8.7
10
*
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
50.4
8.7
10
*
SPAT1358
SPAT
Referral to psychiatric observation (M1 referral)
50.4
8.7
10
*
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
7.7
8.7
19
25
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
8.6
109
570
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.7
8.6
58
223
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
7.0
8.6
20
29
SGA01
NOMESCO Finland
Tooth opening as first aid
1.7
8.5
178
1104
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.1
8.5
46
155
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
8.5
165
999
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.6
8.5
37
106
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
8.5
114
610
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.9
8.5
131
738
N07BA03
ATC
varenicline; oral
2.5
8.5
64
261
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
8.5
419
3221
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.0
8.5
32
81
F50.8
ICD-10 Finland
Other eating disorders
27.7
8.5
11
*
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
20.2
8.5
12
6
F32
ICD-10 Finland
Depressive episode
3.0
8.5
46
156
X58
ICD-10 Finland
Exposure to other specified factors
1.8
8.4
146
855
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.3
8.4
30
72
RS310
NOMESCO Finland
NA
90.7
8.4
9
*
ICB01
SPAT
NA
90.7
8.4
9
*
N05AX16
ATC
brexpiprazole; oral
90.7
8.4
9
*
W19
ICD-10 Finland
Unspecified fall
2.1
8.4
93
462
K85
ICPC
Elevated blood pressure
1.9
8.4
119
652
29699
ICD-8 Finland
Affective psychoses, Unspecified
+∞
8.3
8
*
R78.8
ICD-10 Finland
Finding of other specified substances, not normally found in blood
+∞
8.3
8
*
F23.21
ICD-10 Finland
Acute schizophrenia-like psychosis with acute stress factor
+∞
8.3
8
*
IEP01
NOMESCO Finland
Psychoeducation, family
+∞
8.3
8
*
F06.7
ICD-10 Finland
Mild cognitive disorder
5.9
8.3
22
38
K07
ICPC
Swollen ankles/oedema
3.4
8.3
39
119
V03AB30
ATC
NA
10.8
8.3
15
14
N03AF02
ATC
oxcarbazepine; oral
3.2
8.3
41
130
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
14.6
8.2
13
9
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
8.2
91
452
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.2
400
3062
N99
ICPC
Neurological disease other
7.6
8.2
18
24
IAZ99
NOMESCO Finland
Other psychiatric consultation
33.6
8.1
10
*
WYA20
NOMESCO Finland
Home visit
6.9
8.1
19
28
OAA67
SPAT
NA
0.3
8.1
17
550
2971A
ICD-9 Finland
Paranoid states, Paranoia
22.2
8.0
11
5
29540
ICD-8 Finland
Acute schizophrenia episode
22.2
8.0
11
5
A13
ICPC
Concern/fear medical treatment
5.6
8.0
22
40
S06
ICPC
Rash localized
2.5
8.0
61
251
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.0
8.0
30
76
SPAT1244
SPAT
Occupational therapy
6.6
7.9
19
29
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.7
7.9
33
92
R29
ICPC
Respiratory symptom/complaint other
2.3
7.9
69
305
IHZ07
SPAT
NA
13.1
7.9
13
10
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
7.9
148
890
S04
ICPC
Lump/swelling localized
2.0
7.8
93
475
J01FF01
ATC
clindamycin; systemic
1.6
7.8
251
1748
X23
ICPC
Fear sexually transm dis female
2.4
7.8
64
276
OAA80
SPAT
NA
0.2
7.8
8
379
R4120
NOMESCO Finland
Occupational therapy
2.4
7.8
66
288
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
10.9
7.8
14
13
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
3.7
7.8
32
88
Z01.2
ICD-10 Finland
Dental examination
1.5
7.7
418
3255
SPAT1139
SPAT
Nutrition survey
3.2
7.7
39
126
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
6.4
7.7
19
30
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
7.7
53
207
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
15.1
7.7
12
8
F12.29
ICD-10 Finland
Addiction caused by cannabis UNS
45.3
7.7
9
*
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.1
7.7
87
433
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.9
7.7
30
79
L12
ICPC
Hand/finger symptom/complaint
1.8
7.6
136
805
Z11
ICPC
Compliance/being ill problem
11.9
7.6
13
11
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
25.2
7.6
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.6
233
1607
F20.5
ICD-10 Finland
Residual schizophrenia
10.1
7.5
14
14
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.5
159
989
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.0
7.5
28
71
SPAT1167
SPAT
Insertion of urinary catheter
3.7
7.5
31
86
T90.5
ICD-10 Finland
Sequelae of intracranial injury
7.2
7.5
17
24
S09
ICPC
Infected finger/toe
3.4
7.5
34
102
R02
ICPC
Shortness of breath/dyspnoea
1.9
7.5
104
565
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.5
7.5
56
232
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.9
7.4
102
551
IEV99
SPAT
NA
80.6
7.4
8
*
IFA01
SPAT
NA
80.6
7.4
8
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.1
7.4
38
125
D11
ICPC
Diarrhoea
1.8
7.4
118
672
P58
ICPC
Psychological, Therapeutic counselling/listening
4.4
7.4
25
58
K25
ICPC
Fear of hypertension
3.4
7.4
33
98
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
2.1
7.3
83
417
Z07
ICPC
Education problem
8.4
7.3
15
18
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.9
7.3
101
547
R33
ICD-10 Finland
Retention of urine
2.4
7.3
58
247
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
5.0
7.3
22
45
F60.4
ICD-10 Finland
Histrionic personality disorder
+∞
7.3
7
*
2963D
ICD-9 Finland
Affective psychoses, Major depressive disorder, recurrent episode[PSYCHOSIS BIPOLARIS DEPRESSIVA,VAIKEA-ASTEINEN]
+∞
7.3
7
*
2962B
ICD-9 Finland
Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,LIEVÄASTEINEN]
+∞
7.3
7
*
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
+∞
7.3
7
*
2961A
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]
+∞
7.3
7
*
R3140
NOMESCO Finland
Training in communicative skills
+∞
7.3
7
*
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
+∞
7.3
7
*
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
6.3
7.3
18
29
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.2
166
1058
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.2
122
707
R63.4
ICD-10 Finland
Abnormal weight loss
3.3
7.2
34
105
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.9
7.2
28
74
R55
ICD-10 Finland
Syncope and collapse
2.0
7.2
88
457
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
30.2
7.2
9
*
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
30.2
7.2
9
*
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
20.2
7.1
10
5
-1
ICPC
NA
4.2
7.1
25
60
K02.2
ICD-10 Finland
Caries of cementum
2.8
7.1
43
158
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.8
7.1
43
158
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
12.1
7.1
12
10
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
12.1
7.1
12
10
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.9
7.1
41
145
SPAT1284
SPAT
Extensive health certificate
3.1
7.1
36
118
OAB95
SPAT
NA
0.2
7.0
8
359
J96.0
ICD-10 Finland
Acute respiratory failure
10.1
7.0
13
13
U05
ICPC
Urination problems other
2.9
7.0
41
146
D07AA02
ATC
hydrocortisone; topical
1.7
7.0
137
833
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
7.0
45
170
R30.0
ICD-10 Finland
Dysuria
3.0
7.0
37
125
A05
ICPC
Feeling ill
2.2
7.0
71
341
N05AE03
ATC
sertindole; oral
13.9
6.9
11
8
TAB00
NOMESCO Finland
Lumbar puncture
2.5
6.9
49
198
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.8
139
857
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
8.3
6.8
14
17
F20.10
ICD-10 Finland
Raise schizophrenia continuously
9.4
6.8
13
14
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
9.4
6.8
13
14
K04.08
ICD-10 Finland
Other specified pulpit
2.1
6.8
77
388
R42
ICD-10 Finland
Dizziness and giddiness
1.6
6.8
169
1100
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
40.3
6.8
8
*
IFA99
SPAT
NA
40.3
6.8
8
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
40.3
6.8
8
*
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
40.3
6.8
8
*
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
40.3
6.8
8
*
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
40.3
6.8
8
*
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
16.8
6.7
10
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
6.7
96
526
L16
ICPC
Ankle symptom/complaint
1.9
6.7
100
558
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.7
6.7
153
972
F41
ICD-10 Finland
Other anxiety disorders
4.9
6.7
20
41
F43.02
ICD-10 Finland
Acute stress reaction severe
22.7
6.7
9
*
F50.3
ICD-10 Finland
Atypical bulimia nervosa
22.7
6.7
9
*
H13
ICPC
Plugged feeling ear
1.7
6.6
145
911
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
5.5
6.6
18
33
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.6
6.6
21
46
S31.1
ICD-10 Finland
Open wound of abdominal wall
12.3
6.6
11
9
D19
ICPC
Teeth/gum symptom/complaint
1.5
6.6
258
1874
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
6.5
63
294
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
10.1
6.5
12
12
SPAT1127
SPAT
Enema
10.1
6.5
12
12
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.7
6.5
26
71
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.3
6.5
60
274
F33
ICD-10 Finland
Recurrent depressive disorder
6.2
6.5
16
26
A07AA02
ATC
nystatin; oral
2.4
6.5
53
231
P77
ICPC
Suicide/suicide attempt
70.2
6.4
7
*
V400A
ICD-9 Finland
Mental and behavioural problems, Problems with learning
70.2
6.4
7
*
RF242
NOMESCO Finland
NA
70.2
6.4
7
*
F69
ICD-10 Finland
Unspecified disorder of adult personality and behaviour
70.2
6.4
7
*
29800
ICD-8 Finland
Other psychoses, Reactive depressive psychosis
70.2
6.4
7
*
F10.59
ICD-10 Finland
Alcohol psychosis, mixed type
70.2
6.4
7
*
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
70.2
6.4
7
*
IEZ99
SPAT
NA
70.2
6.4
7
*
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
70.2
6.4
7
*
F12.9
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, unspecified mental and behavioural disorder
70.2
6.4
7
*
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
14.4
6.4
10
7
L02
ICPC
Back symptom/complaint
2.0
6.4
82
435
R11
ICD-10 Finland
Nausea and vomiting
2.1
6.4
69
341
-58
ICPC
Therapeutic counselling/listening
8.2
6.3
13
16
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
6.3
33
111
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
5.5
6.3
17
31
G31.0
ICD-10 Finland
Circumscribed brain atrophy
18.1
6.3
9
5
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
18.1
6.3
9
5
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
+∞
6.3
6
*
P59
ICPC
Psychological, Other therap proced/minor surg NEC
+∞
6.3
6
*
IBB04
NOMESCO Finland
Risk assessment concerning problem behaviour
+∞
6.3
6
*
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
6.3
6
*
2964E
ICD-9 Finland
Affective psychoses, Bipolar affective disorder, manic[PSYCH BIPOLAR CIRCULARIS,VAIKEA-ASTE,PSYKOOT PIIRT]
+∞
6.3
6
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
6.3
6
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
+∞
6.3
6
*
T43.0
ICD-10 Finland
Poisoning: Tricyclic and tetracyclic antidepressants
+∞
6.3
6
*
29440
ICD-8 Finland
Psychosis associated with other physical conditions, Childbirth
+∞
6.3
6
*
XA820
NOMESCO Finland
NA
26.8
6.2
8
*
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
26.8
6.2
8
*
P45
ICPC
Psychological, Observ/health educat/advice/diet
26.8
6.2
8
*
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
26.8
6.2
8
*
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
26.8
6.2
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.2
105
611
R21
ICPC
Throat symptom/complaint
1.5
6.2
218
1540
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.2
156
1020
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.2
377
2974
T27
ICPC
Fear endocrine/metabol disease other
5.4
6.2
17
32
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.1
118
717
G04BD12
ATC
mirabegron; oral
2.0
6.1
72
369
30188
ICD-8 Finland
Personality disorders, Alia definita
12.6
6.1
10
8
R45.1
ICD-10 Finland
Restlessness and agitation
12.6
6.1
10
8
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
12.6
6.1
10
8
P04
ICPC
Feeling/behaving irritable/angry
12.6
6.1
10
8
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.1
215
1522
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.6
6.1
41
162
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.4
6.1
27
81
G56.3
ICD-10 Finland
Lesion of radial nerve
6.7
6.0
14
21
R39.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the urinary system
10.1
6.0
11
11
SPAT1219
SPAT
Assessment of need for vocational rehabilitation
10.1
6.0
11
11
WX110
SPAT
NA
2.3
6.0
52
232
Z63.4
ICD-10 Finland
Disappearance and death of family member
5.2
6.0
17
33
R39.1
ICD-10 Finland
Other difficulties with micturition
3.3
6.0
28
87
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
423
63
102.34
307.65
8.1
5.7
umol/l
409.4
365.4
1.76
387
57
(3028707) Methadone [Presence] in Urine by Screen method
200
110
21.56
256.29
4.6
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
508
1163
6.78
228.76
2.8
1.7
%
1.6
1.4
8.51
466
1035
(3011288) Drugs identified in Urine by Screen method
218
263
9.88
172.64
5.9
2.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
225
347
7.73
144.29
4.3
2.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
409
1142
4.89
138.59
1.9
1.7
nmol/l
1157.4
1199.2
0.37
343
875
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
698
3009
4.09
128.83
4.1
3.3
u/l
29.6
32.2
1.27
663
2876
(3016879) Cocaine [Presence] in Urine
237
447
6.34
124.48
4.4
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
630
2588
3.97
123.48
3.0
3.4
mmol/l
2.4
2.4
1.69
578
2306
(4198724)
80
27
31.64
121.98
3.8
2.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
795
3873
4.03
119.81
7.1
6.5
mmol/l
1.2
1.2
9.21
668
3276
(3000764) Benzodiazepines [Presence] in Urine
241
490
5.88
116.62
4.6
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
736
3461
3.85
115.67
6.3
5.8
mmol/l
1.2
1.2
8.60
687
3155
(3028300) Cannabinoids [Presence] in Urine
240
498
5.76
113.45
4.7
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
564
2251
3.80
113.25
4.1
3.9
ph
7.4
7.4
0.44
104
447
(3027008) Opiates [Presence] in Urine
238
496
5.72
111.90
4.6
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
231
493
5.55
105.48
4.7
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1058
7208
4.56
79.10
6.7
3.6
pmol/l
14.5
14.6
1.00
1012
6613
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
613
3052
3.03
78.37
2.3
1.8
pmol/l
95.3
96.3
0.21
352
1609
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1025
6861
4.12
78.00
8.3
7.2
u/l
75.2
75.8
0.18
984
6478
(3021960) Folate [Moles/volume] in Serum or Plasma
418
1678
3.27
77.92
1.7
1.5
nmol/l
18.9
21.0
2.14
381
1448
(3024561) Albumin [Mass/volume] in Serum or Plasma
652
3421
2.95
74.67
4.7
4.8
g/l
35.7
36.3
1.81
616
3187
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
57
30
19.88
73.13
3.2
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
538
2664
2.83
66.81
2.8
2.4
u/l
53.9
57.5
1.54
492
2488
(3006315) Basophils [#/volume] in Blood
759
4637
2.69
59.85
7.8
5.8
e9/l
0.0
0.0
0.25
665
4076
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
482
2371
2.71
59.05
2.8
2.0
u/l
289.6
255.8
0.25
463
2242
(3001604) Monocytes [#/volume] in Blood
755
4624
2.66
58.84
7.8
5.8
e9/l
0.6
0.6
2.73
663
4056
(3013115) Eosinophils [#/volume] in Blood
773
4810
2.66
57.95
9.1
6.0
e9/l
0.2
0.2
0.10
692
4275
(3013650) Neutrophils [#/volume] in Blood by Automated count
830
5351
2.73
57.81
16.2
8.7
e9/l
4.3
3.9
4.27
739
4722
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
732
4468
2.60
56.60
6.1
6.1
umol/l
8.9
11.6
16.97
683
4252
(3019198) Lymphocytes [#/volume] in Blood
761
4803
2.56
53.68
8.0
5.8
e9/l
2.0
2.0
0.41
671
4299
(42870588) Differential panel, method unspecified - Blood
556
3042
2.52
53.38
6.6
5.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
958
6798
2.92
52.54
6.0
2.8
u/l
48.6
43.8
0.65
912
6457
(3013826) Glucose [Moles/volume] in Serum or Plasma
787
5080
2.55
52.34
5.6
4.4
mmol/l
6.7
6.6
0.47
726
4697
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
353
1573
2.75
51.43
1.8
1.6
pmol/l
446.8
32018297.3
1.74
314
1343
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
313
1310
2.87
51.40
2.7
2.9
mmol/l
2.5
2.4
2.94
272
1150
(3009508) Creatinine [Moles/volume] in Urine
481
2516
2.51
50.16
3.9
3.2
mmol/l
6.7
8.2
8.06
423
2155
(3006504) Eosinophils/100 leukocytes in Blood
706
4389
2.45
50.14
7.8
5.9
%
2.7
2.9
1.13
669
4110
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1113
8706
4.23
49.70
8.5
4.2
mu/l
1.9
2.1
0.67
1074
8067
(3020191) Ethanol [Moles/volume] in Serum or Plasma
56
57
10.25
49.24
1.6
1.5
promille
0.8
1.2
1.01
42
47
(3019069) Monocytes/100 leukocytes in Blood
706
4419
2.42
48.93
8.1
6.1
%
8.3
8.5
1.26
672
4175
(3022096) Basophils/100 leukocytes in Blood
681
4249
2.37
46.77
7.9
6.0
%
0.6
0.7
2.42
645
3993
(3019150) Specific gravity of Urine by Refractometry
385
1874
2.54
46.15
4.3
3.4
kg/l
1.0
1.0
1.51
59
289
(3018010) Neutrophils/100 leukocytes in Blood
708
4534
2.34
45.17
7.9
5.7
%
57.0
56.5
0.50
667
4291
(3026782) Osmolality of Urine
337
1562
2.60
44.54
3.1
2.5
mosm/kgh2o
459.6
562.5
12.51
283
1343
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
282
1208
2.74
43.56
2.1
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
708
4603
2.29
42.62
7.9
5.9
%
28.4
28.8
0.41
667
4334
(40758558) Short blood count panel - Blood
419
2190
2.39
42.35
9.6
6.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
404
2083
2.41
42.07
4.7
4.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
36
23
16.10
41.86
3.3
1.5
umol/l
130.4
63.1
0.80
15
11
(44816559) Phosphatidylethanol [Mass/volume] in Blood
86
172
5.30
41.21
1.5
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
583
3567
2.22
39.86
2.5
2.2
nmol/l
71.0
75.8
4.02
551
3258
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
44
6
76.16
39.17
1.7
3.5
umol/l
15.5
18.9
—
44
6
(3044889) 12 lead EKG panel
859
6208
2.30
37.94
4.3
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
205
815
2.82
36.04
2.0
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
206
823
2.81
35.87
2.1
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1150
9708
4.31
34.86
24.3
12.3
mmol/l
139.2
139.7
5.41
1134
9446
(3026008) Bacteria identified in Urine by Culture
419
2342
2.20
34.83
3.4
2.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
824
5971
2.17
34.42
5.7
3.7
e6/l
1780.8
2680.7
0.21
19
74
(3003458) Phosphate [Moles/volume] in Serum or Plasma
230
999
2.61
33.84
4.3
5.7
mmol/l
1.0
1.0
0.20
220
932
(3021589) Normoblasts [#/volume] in Blood
626
4126
2.06
33.27
11.9
8.6
e9/l
0.0
0.0
0.01
513
3399
(3002032) Base excess in Venous blood by calculation
165
610
2.97
33.01
2.9
3.5
mmol/l
1.8
1.8
0.03
131
492
(3023103) Potassium [Moles/volume] in Serum or Plasma
1148
9749
4.09
32.97
24.1
12.3
mmol/l
4.0
4.0
0.53
1133
9468
(3012095) Magnesium [Moles/volume] in Serum or Plasma
269
1272
2.43
32.95
3.7
3.4
mmol/l
0.8
0.8
0.12
248
1200
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1106
9190
3.21
32.85
6.1
3.8
mmol/l
6.0
5.8
5.44
1042
8481
(3003181) Sodium [Moles/volume] in Urine
57
98
6.05
32.02
1.4
1.3
mmol/l
56.9
63.7
0.59
40
85
(3037467) Urinalysis macro (dipstick) panel - Urine
859
6424
2.14
31.67
5.2
3.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
362
1990
2.17
30.72
2.1
2.0
mg/l
2.7
2.9
0.32
315
1708
(3021387) Prolactin [Units/volume] in Serum or Plasma
127
433
3.16
29.14
2.0
1.6
mu/l
554.6
280.7
4.93
108
390
(3002582) Erythrocytes [#/volume] in Urine
419
2497
2.03
28.25
3.7
2.8
e6/l
26.7
90.0
1.43
325
1893
(3013707) Erythrocyte sedimentation rate by Westergren method
883
6804
2.08
28.20
4.2
3.8
mm/h
11.1
10.4
0.76
825
6353
(3023183) Ammonium ion [Moles/volume] in Plasma
66
151
4.56
26.93
2.3
3.4
umol/l
31.4
36.2
1.24
61
130
(3018095) Leukocytes [#/volume] in Urine
480
3044
1.95
26.76
4.2
3.2
e6/l
46.5
99.2
1.74
339
2075
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
183
792
2.54
26.74
2.5
2.5
u/l
28.6
39.1
1.14
153
681
(3036481) Cortisol [Moles/volume] in Serum or Plasma
179
778
2.52
25.88
2.2
2.1
nmol/l
366.0
374.1
0.21
163
721
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
143
556
2.78
25.85
3.3
3.9
ng/l
85.6
78.7
0.25
129
500
(3000850) Epithelial cells [#/volume] in Urine
307
1680
2.11
25.72
3.1
2.3
e6/l
7.1
5.9
0.71
265
1479
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
140
544
2.78
25.32
2.6
3.5
pmol/l
4.3
4.7
3.48
115
492
(36304419) Bacteria [Presence] in Urine
376
2259
1.96
24.06
3.5
2.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
46
85
5.58
23.97
1.6
1.4
mosm/kgh2o
287.0
280.6
0.71
35
68
(3030467) Casts [#/volume] in Urine by Automated count
377
2281
1.95
23.54
3.6
2.8
e6/l
0.3
0.4
0.93
281
1700
(3000991) Gas panel - Venous blood
142
579
2.64
23.33
7.1
9.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
81
243
3.50
22.76
1.6
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
167
765
2.37
21.35
2.3
2.8
%
1.9
1.7
1.24
149
694
(3017143) Hepatitis C virus Ab [Presence] in Serum
248
1338
2.07
21.14
1.7
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
149
664
2.42
20.22
5.6
7.7
mmol/l
8.1
8.8
0.57
143
639
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
76
238
3.34
19.96
2.2
2.2
ug/l
864.2
495.8
0.36
70
221
(3003396) Base excess in Arterial blood by calculation
173
828
2.27
19.91
7.3
8.6
mmol/l
2.1
1.1
2.84
134
665
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
93
333
2.94
19.49
2.7
3.5
mmol/l
23.9
24.2
0.34
84
302
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1115
9844
2.57
19.48
19.2
11.3
mg/l
21.4
22.6
0.54
954
7555
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
63
179
3.66
19.20
1.2
1.4
e6/l
276.3
539.3
0.24
51
146
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
63
179
3.66
19.20
1.1
1.4
e6/l
71.7
10.7
0.55
48
142
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
455
3072
1.77
19.18
4.0
3.1
ng/l
67.9
35.9
0.35
313
1859
(3014576) Chloride [Moles/volume] in Serum or Plasma
180
889
2.20
19.16
7.5
7.7
mmol/l
103.5
104.5
1.43
174
869
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
106
416
2.70
18.70
1.7
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
622
4616
1.71
18.45
4.1
3.1
estimate
0.0
0.0
0.50
129
866
(46235355) HIV 1 and 2 tests - Meaningful Use set
379
2452
1.79
18.32
2.4
1.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
153
722
2.28
18.15
2.3
2.2
g/l
0.2
0.2
0.22
139
686
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
262
1528
1.91
17.57
2.4
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1004
8603
1.95
17.41
6.4
4.8
mmol/mol
38.9
39.0
0.12
942
8072
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
189
987
2.08
17.35
2.7
2.7
umol/l
8.5
8.6
0.02
145
872
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
22
7
31.97
17.06
4.6
6.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
44
1427
0.28
17.01
1.2
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
24
32
7.63
17.00
1.0
1.0
ng/l
51.7
44.2
0.11
17
19
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
24
32
7.63
17.00
1.0
1.0
ng/l
740.9
635.2
0.34
17
21
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
32
7.63
17.00
1.0
1.0
ng/l
208.7
310.8
1.09
17
21
(3032080) INR in Blood by Coagulation assay
460
3197
1.71
16.99
8.5
7.8
inr
1.1
1.2
1.43
155
979
(3027801) Oxygen [Partial pressure] in Arterial blood
166
833
2.15
16.89
7.5
8.5
kpa
11.8
12.7
1.16
161
797
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
166
833
2.15
16.89
7.5
8.5
kpa
5.4
5.1
2.01
159
796
(3002385) Erythrocyte distribution width [Ratio]
986
8425
1.89
16.88
27.0
13.7
%
13.7
13.5
2.36
973
8238
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
138
644
2.29
16.77
4.3
3.5
mmol/l
1.2
1.2
1.10
120
557
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
109
461
2.50
16.50
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
187
995
2.04
16.26
1.8
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
617
4674
1.65
16.09
4.2
3.1
estimate
0.0
0.0
0.80
129
851
(3016502) Oxygen saturation in Arterial blood
150
737
2.18
16.07
7.9
9.1
%
95.3
95.9
0.80
145
711
(3029937) Albumin [Presence] in Urine by Test strip
364
2402
1.74
16.05
4.6
3.4
estimate
0.0
0.0
1.08
129
870
(3023520) Reticulocytes [#/volume] in Blood
123
557
2.34
16.01
1.8
2.9
e9/l
79.3
69.7
1.48
90
429
(3017509) Phencyclidine [Presence] in Urine
15
11
13.79
15.94
3.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
276
1690
1.82
15.69
2.6
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
248
1477
1.85
15.39
4.3
3.3
ng/l
157.7
614.2
2.86
172
1053
(3022948) Iron [Moles/volume] in Serum or Plasma
213
1209
1.92
15.33
2.1
2.3
umol/l
12.8
13.9
1.52
196
1121
(3011397) Hemoglobin [Presence] in Urine by Test strip
313
2007
1.75
15.15
3.9
3.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
54
165
3.38
14.77
1.2
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
47
132
3.66
14.60
2.8
2.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
101
440
2.41
14.33
8.6
7.7
mmol/l
26.1
24.5
2.67
95
407
(3021601) Nitrite [Presence] in Urine by Test strip
604
4639
1.60
14.25
5.4
4.3
estimate
0.0
0.0
0.00
132
894
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
45
125
3.70
14.20
2.2
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
197
1118
1.91
14.12
2.1
2.3
g/l
2.4
2.4
0.52
175
1040
(40767503) Oxygen content in Capillary blood by calculation
51
155
3.39
14.07
3.5
2.3
%
17.1
17.0
0.04
26
80
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1148
10526
2.58
14.00
14.3
9.0
u/l
28.4
27.6
0.55
1130
10206
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
30
62
4.94
13.84
2.0
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
21
31
6.88
13.61
2.8
2.3
ph
7.3
7.4
—
5
10
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
227
1363
1.82
13.58
2.7
2.5
e6/l
1.0
1.0
0.00
113
773
(3015235) Bicarbonate [Moles/volume] in Capillary blood
58
197
3.04
13.35
3.7
2.2
mmol/l
25.4
25.0
0.30
52
174
(3033658) Prothrombin time (PT) actual/Normal
326
2191
1.67
12.99
4.7
3.6
%
94.8
92.7
0.84
318
2137
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
84
353
2.48
12.88
2.1
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
30
66
4.63
12.87
1.1
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
111
528
2.21
12.83
1.7
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
214
1286
1.81
12.71
2.9
2.6
e6/l
4.3
2.5
0.84
104
696
(1761868) Lipid panel - Serum or Plasma
282
4085
0.60
12.67
3.2
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
333
2272
1.64
12.43
3.2
3.3
mg/l
651.0
284.4
0.51
209
1488
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
179
1025
1.87
12.40
2.1
2.3
%
21.5
24.5
2.02
139
884
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
345
2379
1.63
12.33
1.7
1.6
mmol/l
1.8
1.4
7.01
300
2039
(3010421) pH of Blood
57
203
2.90
12.09
6.3
3.7
ph
7.4
7.4
0.20
48
168
(3052851) Hemolysis interference index of Serum or Plasma
59
218
2.79
11.71
3.8
3.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
50
170
3.02
11.52
6.8
3.8
mmol/l
2.7
2.3
0.52
37
108
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
106
518
2.15
11.45
2.3
2.3
u/l
7798.9
4620.3
0.28
21
217
(3019060) Gas panel - Arterial blood
98
469
2.18
11.16
4.9
5.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1036
9303
1.76
11.11
4.3
3.5
mmol/l
1.5
1.3
11.34
955
8716
(1616796) Gas panel - Central venous blood
50
175
2.94
10.96
5.7
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
148
832
1.89
10.80
5.4
2.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
16
9
17.99
10.74
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
80
360
2.31
10.56
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
51
1232
0.39
10.54
1.4
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1077
9820
1.84
10.45
5.3
4.2
mmol/l
2.7
2.9
10.46
1003
9192
(3020682) Albumin/Creatinine [Ratio] in Urine
337
2391
1.57
10.40
4.1
4.0
mg/mmol
10.1
8.7
0.15
206
1560
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
298
2066
1.59
10.13
2.0
1.7
mg/l
1.1
1.0
0.39
227
1524
(3023410) Appearance of Cerebral spinal fluid
30
80
3.82
10.08
1.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
289
1995
1.59
9.99
2.5
3.0
ng/l
1116.1
1065.0
0.10
237
1673
(3042936) Bacteria identified in Isolate by Culture
193
1203
1.72
9.96
2.2
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
158
930
1.80
9.94
2.4
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
153
900
1.80
9.64
1.6
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
547
2.01
9.57
2.8
2.9
ng/l
149.2
165.5
0.14
85
484
(3020891) Body temperature
60
248
2.49
9.57
7.9
5.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
59
242
2.51
9.57
4.6
6.8
mmol/l
1.3
1.2
0.13
53
214
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
111
591
1.97
9.51
2.4
2.2
ug/l
11.0
7.9
0.32
92
521
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1061
9696
1.73
9.36
4.9
3.9
mmol/l
4.5
4.7
10.70
995
9142
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
130
737
1.86
9.22
1.3
1.2
iu/ml
85.3
143.6
1.52
40
300
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
450
2.08
9.18
3.3
3.0
mmol/l
1.8
1.9
0.14
68
317
(3009343) pH of Capillary blood
93
472
2.05
9.11
3.3
3.0
ph
7.4
7.4
0.39
19
67
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
128
726
1.85
9.07
2.2
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
28
77
3.70
9.03
1.1
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
47
4.53
8.85
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
107
580
1.93
8.71
1.8
3.1
g/l
66.1
67.3
0.67
96
537
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
32
5.37
8.70
1.1
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1054
9661
1.68
8.61
4.8
3.8
mmol/l
1.3
1.5
17.64
986
9067
(3001122) Ferritin [Mass/volume] in Serum or Plasma
526
4220
1.43
8.46
3.0
2.6
ug/l
104.3
109.9
0.34
477
3958
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
19
6.91
8.45
2.6
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
19
6.91
8.45
2.6
2.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
192
2.56
8.23
2.0
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
40
146
2.80
8.18
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
40
146
2.80
8.18
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
143
866
1.74
8.13
16.5
19.9
inr
1.2
1.2
0.26
19
119
(3000494) Fungus identified in Specimen by Culture
167
1060
1.67
7.99
1.7
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
460
3633
1.43
7.93
4.5
3.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
35
4.91
7.90
1.1
1.3
nmol/l
150.4
148.8
0.04
17
35
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
306
2241
1.49
7.83
1.3
1.2
u/ml
1.9
1.6
0.18
84
612
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
81
414
2.02
7.81
9.6
11.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
74
1387
0.50
7.73
1.2
1.4
—
—
—
0
0
(3019225) pH of Specimen
125
739
1.77
7.73
4.9
4.0
—
—
—
0
0
(44806118)
30
96
3.18
7.72
1.9
1.7
—
—
—
0
0
(44790048)
30
96
3.18
7.72
1.9
1.7
—
—
—
0
0
(44790047)
30
96
3.18
7.72
1.9
1.7
—
—
—
0
0
(44790049)
30
96
3.18
7.72
1.9
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1003
9151
1.54
7.60
18.4
10.2
ml/min/173m2
90.5
87.3
4.05
815
7457
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
827
0.38
7.37
1.4
1.4
—
—
—
0
0
(3013512) EKG study
307
2286
1.46
7.14
4.4
3.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1117
10495
1.78
7.13
18.8
10.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
39
4.41
6.97
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
126
770
1.71
6.93
1.1
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
138
867
1.67
6.85
3.2
4.6
u/l
209.1
246.8
2.89
133
822
(3003327) Ova and parasites identified in Stool by Light microscopy
65
323
2.07
6.79
1.7
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
75
393
1.97
6.77
9.2
11.2
mmol/l
24.5
24.5
0.03
68
371
(3024928) Oxygen saturation in Venous blood
39
156
2.55
6.73
1.9
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
273
2008
1.46
6.72
1.8
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
62
304
2.10
6.71
1.8
2.2
g/l
1.4
1.4
0.14
51
268
(3007164) IgA [Mass/volume] in Serum or Plasma
268
1966
1.47
6.68
1.5
1.5
g/l
2.3
2.3
0.25
135
1274
(3016650) Hepatitis A virus Ab [Presence] in Serum
41
173
2.42
6.34
1.1
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
81
447
1.87
6.29
11.4
11.1
%
93.3
94.2
0.84
81
447
(3043409) Potassium [Moles/volume] in Arterial blood
45
201
2.29
6.14
6.7
4.7
mmol/l
3.9
3.9
0.19
40
187
(3004588) Protein electrophoresis panel - Serum or Plasma
84
475
1.83
6.04
1.6
2.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
23
5.26
6.01
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
43
192
2.28
5.88
2.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
64
3.32
5.87
1.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
64
3.32
5.87
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
64
3.32
5.87
1.2
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
24
5.04
5.75
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
82
2.97
5.59
1.4
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
33
4.28
5.56
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
689
0.42
5.48
1.6
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
57
3.37
5.45
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
47
226
2.12
5.40
3.0
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
138
920
1.56
5.38
10.4
5.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
85
2.86
5.26
1.2
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
115
746
1.60
5.05
4.6
4.2
%
0.6
0.9
1.15
36
207
(3019832) Treponema pallidum Ab [Presence] in Serum
197
1437
1.44
4.97
1.7
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
289
2253
1.37
4.97
7.0
4.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
163
2.25
4.82
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
46
230
2.04
4.80
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
10
9.06
4.79
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
138
2.35
4.78
2.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
48
246
1.99
4.69
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
48
246
1.99
4.69
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
122
817
1.55
4.68
5.4
3.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
62
347
1.83
4.67
1.3
1.4
u/l
9.1
9.0
0.01
52
288
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
34
155
2.23
4.49
1.5
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
52
279
1.90
4.47
1.9
2.1
ug/l
2.7
2.4
0.05
47
249
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
76
2.79
4.46
1.4
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
92
583
1.63
4.46
2.7
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
48
251
1.95
4.45
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
43
218
2.01
4.35
1.4
1.5
ug/g
328.6
287.3
0.64
28
123
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
22
4.57
4.30
1.2
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
23
90
2.59
4.23
2.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
83
520
1.64
4.22
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
103
684
1.55
4.12
4.1
4.1
%
0.6
0.6
0.00
25
156
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
25
104
2.43
4.07
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
43
224
1.95
4.05
2.5
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
52
291
1.82
3.96
2.0
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
29
3.82
3.81
1.1
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
26
114
2.31
3.80
1.3
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
45
244
1.88
3.79
1.4
1.9
iu/l
5.8
5.3
0.10
13
94
(3022313) Gas panel - Capillary blood
57
334
1.74
3.74
2.5
3.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
25
4.02
3.70
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
25
4.02
3.70
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
25
4.02
3.70
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1165
11301
1.71
3.65
34.0
16.3
e9/l
256.4
252.2
1.41
1148
11041
(3024731) MCV [Entitic volume]
1166
11314
1.72
3.64
33.7
16.2
fl
91.0
90.4
4.89
1155
11179
(3025159) Blasts/100 leukocytes in Blood
100
680
1.51
3.61
5.2
4.3
%
0.0
0.6
0.63
26
164
(3026361) Erythrocytes [#/volume] in Blood
1166
11316
1.71
3.61
33.8
16.3
e12/l
4.5
4.6
5.04
1151
11032
(3021440) Promyelocytes/100 leukocytes in Blood
104
714
1.50
3.59
5.0
4.3
%
0.1
0.2
1.02
30
190
(3000093) Morphology [Interpretation] in Blood Narrative
18
68
2.67
3.57
1.3
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1166
11320
1.70
3.54
34.0
16.3
e9/l
7.2
6.6
17.50
1150
11035
(3034860) Kappa light chains.free [Mass/volume] in Serum
39
207
1.91
3.52
1.9
4.1
mg/l
42.3
85.2
0.74
30
163
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
207
1.91
3.52
1.9
4.1
mg/l
27.9
30.2
0.26
30
164
(3000963) Hemoglobin [Mass/volume] in Blood
1166
11322
1.70
3.51
34.0
16.4
g/l
135.6
137.6
5.14
1156
11182
(40757373) Influenza virus identified in Isolate
8
13
6.19
3.50
2.3
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
60
364
1.68
3.49
2.6
2.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
80
522
1.57
3.49
1.3
1.3
iu/l
19.8
25.4
0.89
64
451
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
24
107
2.27
3.40
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
47
269
1.78
3.36
1.3
1.3
titre
178.0
80.0
—
5
27
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
29
142
2.07
3.28
1.2
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
1164
11315
1.65
3.26
33.6
16.2
pg
30.3
30.2
0.71
1154
11179
(40761535) Cells panel - Urine sediment
92
633
1.49
3.17
3.5
3.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
166
1.95
3.11
1.7
4.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
8
7.53
3.05
1.3
1.4
ng/l
102.0
88.8
—
6
8
(3001556) Androgen free Index in Serum or Plasma
8
16
5.03
3.05
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
53
324
1.66
3.03
2.1
1.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
5
10.03
2.98
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
321
2707
1.25
2.94
3.9
2.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
46
2.85
2.92
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
347
0.43
2.90
1.5
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
164
1270
1.34
2.89
2.0
2.5
ug/g
110.9
116.6
0.08
128
1024
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
185
1.86
2.89
1.0
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
237
1.76
2.88
1.7
2.2
g/l
9.5
10.7
0.76
36
209
(3037522) Nuclear Ab [Titer] in Serum
167
1304
1.33
2.79
1.5
1.3
titre
610.6
496.2
0.37
34
281
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
299
0.40
2.78
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
124
2.04
2.77
2.0
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
26
131
2.01
2.77
2.6
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
111
2.09
2.74
2.5
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
48
2.73
2.72
1.3
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
16
66
2.44
2.71
2.8
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
230
0.39
2.69
1.2
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
231
0.39
2.69
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
231
0.39
2.69
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
190
1.81
2.68
2.6
4.2
%
57.1
56.4
0.13
34
190
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
141
1.94
2.61
3.5
2.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
94
2.15
2.55
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
33
3.05
2.53
2.9
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
39
2.84
2.48
1.5
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
242
1.68
2.43
1.9
2.2
g/l
2.9
3.1
0.51
34
194
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
35
204
1.74
2.43
2.0
4.0
ratio
3.4
1.3
—
5
24
(3042631) Mycobacterium sp identified in Specimen
21
103
2.06
2.42
3.2
2.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
174
0.34
2.42
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
258
1.65
2.41
1.9
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
258
1.65
2.41
1.9
2.2
g/l
7.3
7.3
0.07
34
200
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
258
1.65
2.41
1.9
2.2
g/l
3.7
3.8
0.02
34
189
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
34
2.96
2.41
1.1
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
34
2.96
2.41
1.8
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
182
1.78
2.41
2.6
3.8
e9/l
4.5
4.1
0.35
32
182
(3005719) IgG [Mass/volume] in Serum or Plasma
98
722
1.39
2.40
2.9
2.8
g/l
10.8
10.7
0.11
87
658
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
64
2.36
2.39
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
58
2.43
2.37
1.8
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
8
6.27
2.37
1.2
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
71
2.27
2.35
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
52
340
1.55
2.33
2.0
1.9
s
20.6
21.1
0.39
47
299
(4024509)
15
65
2.32
2.32
1.7
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
28
3.23
2.31
4.2
4.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
72
2.24
2.28
1.1
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
13
4.63
2.27
2.8
2.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
73
2.21
2.21
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
73
2.21
2.21
2.3
1.4
%
29.2
39.7
—
9
48
(4010399)
79
571
1.41
2.18
1.5
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
27
151
1.81
2.17
1.2
1.1
iu/ml
43.8
195.5
—
5
39
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
33
197
1.69
2.14
1.7
2.2
nmol/l
0.8
0.9
0.46
25
170
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
18
88
2.06
2.12
2.0
2.3
pg
33.7
33.2
0.16
18
88
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
8
25
3.21
2.09
1.0
1.2
—
632.4
—
0
5
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
56
802
0.68
2.08
1.4
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
128
1604
0.77
2.02
2.1
2.7
ug/l
0.7
0.7
0.12
85
934
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
38
2.65
2.01
1.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
38
2.65
2.01
1.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
38
2.65
2.01
1.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
38
2.65
2.01
1.0
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
32
2.83
2.00
1.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
77
2.09
1.97
1.4
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
16
3.76
1.93
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
34
531
0.63
1.93
1.2
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
71
2.13
1.92
1.5
3.1
%
65.0
52.7
—
7
56
(3017732) Neutrophils [#/volume] in Blood
88
663
1.35
1.92
2.6
2.6
e9/l
4.5
4.0
1.01
76
553
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
145
1172
1.27
1.91
1.7
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
212
1.62
1.90
3.4
2.8
u/ml
0.3
0.3
0.12
22
109
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
22
3.19
1.88
2.4
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
151
1.74
1.88
2.2
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
29
174
1.68
1.87
1.3
1.4
nmol/l
0.3
0.4
0.52
22
136
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
100
1.91
1.86
1.2
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
17
3.54
1.84
1.5
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
40
2.51
1.84
1.1
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
12
4.18
1.82
1.6
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
199
1.62
1.81
2.0
2.4
ug/min
147.7
102.5
0.25
18
129
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
53
2.28
1.81
1.3
1.3
e6/l
97654.5
23818.0
—
6
29
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
35
2.58
1.80
1.1
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
146
1.73
1.78
1.8
1.7
—
—
—
0
0
(4027681)
13
60
2.18
1.78
1.2
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
18
3.34
1.75
2.5
2.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
13
3.86
1.71
4.0
1.6
mmol/l
1.3
1.3
—
5
13
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.86
1.71
1.2
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
13
3.86
1.71
1.2
1.2
umol/l
18.9
18.3
—
5
13
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
23
382
0.59
1.71
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
75
2.01
1.70
5.5
3.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
62
2.11
1.66
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
62
2.11
1.66
1.2
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
76
577
1.34
1.61
1.2
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
14
3.58
1.61
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
107
1.79
1.55
1.3
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
20
115
1.75
1.53
1.3
1.3
nmol/l
0.6
0.6
0.08
20
109
(3000492) Spirometry study
82
1044
0.77
1.50
1.7
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
44
310
1.44
1.47
2.4
3.7
g/l
0.1
0.2
4.02
20
134
(3017446) Testosterone [Moles/volume] in Serum or Plasma
98
784
1.27
1.45
2.8
2.2
nmol/l
11.4
13.5
1.97
88
712
(4306422)
25
156
1.62
1.44
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
32
212
1.52
1.44
1.2
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
66
1.98
1.43
1.2
1.1
—
—
—
0
0
(4268621)
19
110
1.74
1.43
2.2
2.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
20
118
1.71
1.42
3.3
3.2
%
1.5
1.3
0.18
11
103
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
23
2.62
1.37
1.7
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
17
2.95
1.36
1.2
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
26
167
1.57
1.35
1.2
1.2
u/ml
1.8
6.2
—
10
56
(3008757) Leukocyte morphology finding [Identifier] in Blood
16
90
1.79
1.33
3.7
3.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
152
1.59
1.32
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
26
168
1.56
1.32
1.2
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
150
0.46
1.31
1.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
9
43
2.10
1.30
1.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
185
1.53
1.30
1.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
106
1.71
1.30
2.3
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
34
2.36
1.29
1.1
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
49
362
1.37
1.28
1.2
1.2
u/ml
0.9
1.2
—
5
27
(3034770) Mitochondria Ab [Titer] in Serum
39
277
1.42
1.28
1.3
1.3
—
1510.0
—
0
8
(3004451) EKG impression Narrative
9
44
2.05
1.27
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
137
1159
1.21
1.24
1.3
1.2
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
19
2.64
1.21
1.2
1.6
g/l
30.6
30.1
—
5
12
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
17
101
1.69
1.20
4.2
5.8
mg/l
11.1
10.7
0.14
12
93
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
71
1.84
1.19
1.8
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
241
2151
1.15
1.15
2.0
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
71
564
1.27
1.15
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
65
1.85
1.13
1.1
1.3
—
—
—
0
0
(4035726)
57
729
0.77
1.13
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
29
200
1.46
1.13
1.2
1.4
u/ml
94.6
124.3
—
7
40
(3028026) IgM [Mass/volume] in Serum or Plasma
72
575
1.27
1.12
1.9
1.9
g/l
1.8
1.4
0.41
63
530
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
57
444
1.30
1.08
1.4
1.3
miu/ml
140.7
223.9
0.79
11
233
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
89
1.69
1.08
3.9
1.9
—
—
—
0
0
(4146454)
13
74
1.76
1.07
3.2
2.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
184
1620
1.16
1.07
1.3
1.2
iu/ml
20.9
28.8
0.87
57
519
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
105
1.63
1.06
3.4
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
105
1.63
1.06
2.8
2.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
59
465
1.28
1.04
1.7
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
163
1.48
1.02
1.2
1.2
u/ml
4.3
4.0
0.04
12
66
(3010838) Calcium [Moles/time] in 24 hour Urine
9
48
1.88
1.00
1.1
1.6
—
11.2
—
0
5
(40768793) Breast Pathology biopsy report
13
213
0.61
1.00
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
23
2.18
0.98
1.2
2.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
1.3
—
—
—
0
0
(4094501)
15
235
0.63
0.96
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
54
1.86
0.96
7.3
4.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
120
1030
1.18
0.96
5.3
3.9
%
29.7
31.8
1.34
98
729
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
69
1.75
0.96
2.3
2.3
u/field
1.4
2.3
—
7
34
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
70
570
1.24
0.96
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
27
2.23
0.93
1.2
2.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
142
1.49
0.92
2.2
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
167
1.45
0.92
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
235
1.37
0.92
1.5
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
28
2.15
0.91
2.7
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
29
2.07
0.89
1.2
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
144
1.47
0.87
1.3
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
1.5
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
192
0.62
0.86
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
204
1.38
0.85
1.6
1.8
e6/l
4796.1
12208.9
1.71
17
158
(3045142) Bone marrow Pathology biopsy report
14
88
1.60
0.84
1.1
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
129
1.48
0.83
1.6
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
306
2831
1.11
0.83
2.2
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
980
9580
1.12
0.82
25.6
11.7
%
39.8
40.6
2.14
655
7561
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
33
429
0.76
0.79
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
33
429
0.76
0.79
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
33
429
0.76
0.79
1.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
33
1.82
0.79
3.7
2.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
33
428
0.76
0.78
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
34
1.77
0.76
1.3
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
34
1.77
0.76
3.7
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
37
288
1.29
0.76
2.5
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
59
1.70
0.76
3.7
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
149
1.42
0.76
1.2
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
171
1540
1.13
0.75
1.3
1.2
u/ml
3.4
10.4
3.79
55
648
(3049717) Cytology report of Urine Cyto stain
34
263
1.30
0.73
2.2
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
39
1.80
0.72
1.0
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
39
1.80
0.72
1.0
2.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
68
1.62
0.71
1.3
1.4
g/l
38.6
35.2
0.57
11
58
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
11
69
1.60
0.68
1.6
1.4
—
71.2
—
0
9
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
103
1.46
0.65
1.3
1.3
nmol/l
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
767
7450
1.08
0.64
3.5
3.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
12
79
1.52
0.62
1.3
1.3
e6/l
288461.7
130428.5
—
6
54
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
121
1.41
0.62
1.5
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
96
1.46
0.61
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.0
1.8
—
—
—
0
0
(4034850)
36
289
1.25
0.61
9.1
7.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
271
1.26
0.61
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
188
1726
1.11
0.61
1.6
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
139
1.37
0.60
1.5
1.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
80
1.50
0.60
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
283
1.24
0.57
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
287
3047
0.92
0.56
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
90
0.55
0.55
1.4
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
50
422
1.19
0.55
1.7
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
197
2122
0.91
0.54
3.3
3.7
%
23.0
20.9
0.89
71
893
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
160
1.32
0.53
1.2
1.4
mmol/l
9.4
7.6
0.70
14
109
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
74
1.49
0.53
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
39
1.54
0.53
7.3
3.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
39
1.54
0.53
1.5
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
99
0.60
0.52
1.3
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
65
1.39
0.50
2.3
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
367
0.81
0.49
1.4
1.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
46
1.52
0.48
1.0
1.1
—
4.6
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
76
1.45
0.48
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
85
1.42
0.47
2.0
2.4
e9/l
1.1
1.3
—
6
50
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
77
1.43
0.45
1.4
1.3
g/l
5.2
6.9
—
6
53
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
77
1.43
0.45
1.4
1.3
g/l
2.4
2.7
—
5
52
(3024139) IgG subclass 3 [Mass/volume] in Serum
11
77
1.43
0.45
1.4
1.3
g/l
0.2
0.3
—
5
51
(40768795) Lymph node Pathology biopsy report
5
85
0.59
0.45
1.4
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
39
459
0.84
0.44
1.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
458
4417
1.06
0.43
3.9
3.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
31
1.62
0.43
1.0
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
218
0.78
0.42
1.0
1.1
u/ml
7.2
7.6
—
8
122
(3042733) HLA Ab [Presence] in Serum
5
33
1.52
0.41
1.6
4.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
33
1.52
0.41
2.4
2.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
33
1.52
0.41
4.4
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.2
—
1.9
—
0
16
(3012441) Differential panel - Pleural fluid
8
59
1.36
0.41
1.5
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
59
1.36
0.41
1.0
2.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
3.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
905
8907
1.06
0.40
31.3
13.6
g/l
332.2
333.6
4.65
899
8838
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
60
1.34
0.40
3.6
1.7
—
—
—
0
0
(3036603) Volume of Urine
8
60
1.34
0.40
1.3
1.7
—
2000.6
—
0
12
(3011648) Oxygen content in Venous blood
8
60
1.34
0.40
1.5
1.9
%
13.4
10.9
—
8
60
(3035880) pH of Pleural fluid
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
29
345
0.84
0.39
1.4
1.4
—
—
—
0
0
(44813793)
9
67
1.35
0.38
1.1
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
29
344
0.84
0.38
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
26
216
1.21
0.37
1.6
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
31
364
0.85
0.36
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
234
2225
1.06
0.36
1.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
355
3683
0.95
0.35
2.0
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
199
1.21
0.35
3.6
4.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
43
1.40
0.35
1.3
1.2
u/l
88.5
76.4
—
6
37
(3022145) Colonoscopy Study observation
108
999
1.09
0.34
1.2
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
60
667
0.89
0.34
1.2
1.3
u/ml
304.5
266.7
0.08
54
620
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
243
0.82
0.34
1.1
1.1
u/ml
0.4
1.8
—
10
100
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
91
1.32
0.34
1.5
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
81
740
1.10
0.33
3.0
4.6
ug/l
17.3
28.0
0.25
58
596
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
191
1.21
0.33
4.8
3.4
mg/l
23.8
27.4
0.16
11
119
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
46
1.31
0.33
1.2
1.0
iu/ml
245.3
233.3
—
6
46
(40768443) Skin Pathology biopsy report
42
370
1.14
0.32
1.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
208
0.81
0.31
1.0
1.1
u/ml
0.5
1.5
—
5
89
(3010726) Horse dander IgE Ab [Units/volume] in Serum
17
207
0.82
0.30
1.0
1.1
u/ml
3.8
2.4
—
6
59
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
148
1.22
0.29
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
109
0.73
0.29
1.6
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
64
1.25
0.27
1.8
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
168
1.19
0.27
1.7
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
31
352
0.88
0.26
1.4
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
320
0.87
0.26
2.0
1.6
iu/ml
0.0
0.3
—
6
54
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
74
1.22
0.25
1.4
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
96
1.25
0.24
1.9
2.1
—
—
—
0
0
(4062490)
10
78
1.28
0.24
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
27
237
1.14
0.23
1.3
1.2
u/ml
7.9
9.6
—
7
40
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
46
419
1.10
0.22
3.0
3.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
91
0.77
0.22
2.1
1.4
g/l
1.0
1.0
—
7
91
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
237
2291
1.04
0.22
2.7
2.5
umol/l
1943.4
5434.3
1.22
202
2044
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
107
1.22
0.21
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
1.2
u/l
41.0
13.5
—
5
35
(3010937) Rubella virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
10
0.00
0.21
0.0
3.3
—
47.5
—
0
10
(40762814) Titanium [Mass/volume] in Blood
0
10
0.00
0.21
0.0
2.2
—
3.9
—
0
5
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(4038314)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
4.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
4.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
48
1.25
0.20
1.0
1.4
—
18.7
—
0
11
(3012565) Volume of 24 hour Urine
6
48
1.25
0.20
1.5
2.9
ml
2761.7
2018.1
—
6
43
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
288
1.11
0.20
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
241
1.12
0.19
1.1
1.2
—
—
—
0
0
(4281824)
11
90
1.22
0.19
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
110
1154
0.95
0.19
1.3
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
53
1.13
0.18
8.5
7.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
26
290
0.89
0.18
3.4
3.6
u/ml
18.2
1135.1
1.34
21
247
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
5
68
0.73
0.17
2.0
1.2
—
46.2
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
69
1.16
0.16
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
69
1.16
0.16
1.1
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.3
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
26
235
1.11
0.15
1.3
1.2
u/ml
3.1
2.8
—
5
29
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
219
1.10
0.12
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
210
1.10
0.12
1.9
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
144
1.11
0.10
2.2
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
135
1.11
0.09
1.1
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
47
1.06
0.09
1.0
1.1
miu/ml
1945.4
1430.3
—
5
47
(1002224) Polysomnography panel
44
462
0.95
0.09
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
155
0.90
0.09
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
165
1.09
0.08
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
15
136
1.10
0.08
2.0
1.9
g/l
0.6
1.0
—
10
102
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
107
1.12
0.08
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
107
1.12
0.08
1.3
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
60
0.83
0.08
1.4
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
64
1.09
0.08
1.1
3.5
u/ml
11.6
77.6
—
7
64
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
39
372
1.05
0.07
1.7
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
66
682
0.97
0.07
2.6
2.4
ml/min/173m2
65.8
72.8
0.58
28
250
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
108
1.11
0.07
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
108
1.11
0.07
1.3
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
80
0.87
0.07
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
83
0.84
0.07
1.9
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
90
0.89
0.06
2.0
2.4
mmol/l
4.1
4.1
—
8
90
(3035285) Chloride [Moles/volume] in Venous blood
8
90
0.89
0.06
2.0
2.4
mmol/l
103.3
105.6
—
8
90
(3021788) Differential panel - Synovial fluid
17
158
1.08
0.06
2.3
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
269
2661
1.01
0.06
3.6
4.2
ug/l
1.7
2.1
1.49
237
2425
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
182
0.93
0.05
1.0
1.0
u/ml
11.4
3.7
—
10
81
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
110
1.09
0.05
1.3
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
110
1.09
0.05
2.6
1.7
%
65.3
55.5
—
7
76
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
110
1.09
0.05
1.3
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
160
1.06
0.04
1.4
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
121
1.08
0.03
1.1
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
168
0.95
0.02
1.0
1.1
u/ml
3.3
4.9
0.26
11
74
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
43
438
0.98
0.01
1.3
1.7
mg/l
6.8
4.4
0.27
33
287
(3008898) HLA-B27 [Presence]
42
413
1.02
0.01
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
40
396
1.01
0.00
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
64
0.94
0.00
4.3
3.7
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
33.3
—
0
5
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
63.3
—
0
6
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.4
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
394.9
—
0
8
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
191.5
—
0
6
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.7
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
76
0.92
0.00
1.9
1.4
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
69
1.01
0.00
1.3
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
17.4
—
0
5
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
76
0.92
0.00
2.4
2.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
59
0.85
0.00
1.4
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
69
1.01
0.00
1.3
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
65
0.92
0.00
2.2
2.2
ml
653.3
593.7
—
6
44
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
5
50
1.00
0.00
1.6
2.3
min
546.8
507.9
—
5
37
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
416.8
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
88
0.91
0.00
2.0
2.4
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
6.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_MANIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MANIA | 2.482 [2.14, 2.88] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.039 |
During the follow-up period (1.1.1998 — 31.12.2019), 843 out of 3677 females with F5_MANIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MANIA | 3.049 [2.61, 3.56] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 945 out of 3517 males with F5_MANIA died.
Mortality risk
Mortality risk for people of age
years, who have F5_MANIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.167% | 0.515% |
| 5 | 1.046% | 3.524% |
| 10 | 2.924% | 8.751% |
| 15 | 5.769% | 16.259% |
| 20 | 10.569% | 25.66% |
Relationships between endpoints
↥Index endpoint: F5_MANIA – Manic episode
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data